Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

The Index › Metabolic medicine › Whose sales may the drugs shrink?

Coca-Cola

KO

Coca-Cola sells sugary and diet soft drinks worldwide. We follow it because its sales depend on eating and drinking habits that weight-loss drugs and health trends may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
KO
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$95.67
close of 6 Nov 2026 · Massive and Yahoo agree
The day's range$93.00 – $96.31
6 Nov 2026 · both providers agree
52-week range$67.27 – $97.39
intraday low 7 Jan 2026 · intraday high 5 Nov 2026 · 251 sessions to 6 Nov 2026 · both providers agree
Market value$411.6 billion
the 6 Nov 2026 close × 4,301,902,335 shares outstanding on the 10-Q cover, as of 26 Oct 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

28 Oct 202610-Q · period ending 2 Oct 2026
27 Oct 20268-K · period ending 27 Oct 2026
29 Jul 202610-Q · period ending 3 Jul 2026
28 Jul 20268-K · period ending 28 Jul 2026
On July 28, 2026, covering its second quarter, the company reported net revenues up 7 percent to $13.4 billion. the piece
16 Jul 20268-K · period ending 16 Jul 2026
25 Jun 20268-K · period ending 18 Jun 2026
1 May 20268-K · period ending 29 Apr 2026
30 Apr 202610-Q · period ending 3 Apr 2026
28 Apr 20268-K · period ending 28 Apr 2026
20 Feb 20268-K · period ending 19 Feb 2026
20 Feb 202610-K · period ending 31 Dec 2025
10 Feb 20268-K · period ending 10 Feb 2026
14 Jan 20268-K · period ending 13 Jan 2026
10 Dec 20258-K · period ending 10 Dec 2025
23 Oct 202510-Q · period ending 26 Sep 2025
21 Oct 20258-K · period ending 21 Oct 2025
16 Oct 20258-K · period ending 16 Oct 2025
24 Jul 202510-Q · period ending 27 Jun 2025
22 Jul 20258-K · period ending 22 Jul 2025
26 Jun 20258-K · period ending 26 Jun 2025
2 May 20258-K · period ending 30 Apr 2025
1 May 202510-Q · period ending 28 Mar 2025
29 Apr 20258-K · period ending 29 Apr 2025
27 Mar 20258-K · period ending 27 Mar 2025
20 Feb 202510-K · period ending 31 Dec 2024
11 Feb 20258-K · period ending 11 Feb 2025
16 Dec 20248-K · period ending 13 Dec 2024
11 Dec 20248-K · period ending 11 Dec 2024

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-07-29 · period ending 2026-07-03

Read the filing

Machine-readable

/index/KO.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

3 Jul 2026Coca-Cola net revenues growth, Q2 2026: 7 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola net revenues, Q2 2026: $13.4 billionCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola organic revenues growth (non-GAAP), Q2 2026: 6 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola concentrate sales increase, Q2 2026: 4 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola price/mix growth, Q2 2026: 2 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola global unit case volume growth, Q2 2026: 5 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola Asia Pacific unit case volume growth, Q2 2026: 8 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing
3 Jul 2026Coca-Cola Asia Pacific price/mix decline, Q2 2026: 9 percentCoca-Cola Reports Second Quarter 2026 Results and Raises Full Year Guidance, The Coca-Cola Company, July 28, 2026 · filing

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

Same question

Other companies under Whose sales may the drugs shrink?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-07-29 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Coca-Cola. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-07-29
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)